China CDE Clears Elpisciences IND For ES014 To Initiate Phase 1 Study To Treat Advanced Solid Tumours

Elpiscience Biopharmaceuticals, Inc. (Elpiscience), a clinical-stage biopharmaceutical company, announced that the China Center of Drug Evaluation (CDE) for National Medical Products Administration has cleared Elpiscience